StackTerminal.Health

BETA

Rutin (Quercetin-3-rutinoside)

Rutin is a flavonoid glycoside of quercetin with anti-thrombotic, anti-inflammatory, and vascular-protective properties, commonly used for venous insufficiency and edema reduction.

cardiovascularanti thromboticanti inflammatoryantioxidant

Evidence last reviewed: 20 Apr 2026

Evidence
3 records
3 recordsBest grade:Moderate

Moderate evidence suggests that rutin may help reduce symptoms of chronic venous insufficiency and edema. While the findings are promising, more high-quality studies are needed to strengthen the conclusions.

Venous insufficiency symptoms
Patients with chronic venous insufficiency · Systematic review
Moderate

Phlebotonics, including rutosides, probably reduce edema slightly compared to placebo.

Dose: 500 mg
Moderate-certainty evidence suggests slight reduction in edema.
Post-thrombotic syndrome prevention
Patients with chronic venous insufficiency · Systematic review
Moderate

Venoactive compounds are recommended for prevention and treatment of post-thrombotic syndrome.

Dose: 500 mg
Evidence supports use in post-thrombotic syndrome.
Edema reduction
Patients with chronic venous insufficiency · RCT
Moderate
Stacks containing Rutin (Quercetin-3-rutinoside)
Explore all →
No public stacks include this supplement yet.
Community Insights
Forms & usage
How to take it

Take 500-1000 mg daily, preferably with meals.

Capsule
Commonly available in 500 mg doses.
Tablet
Often used for standardized dosing.
Powder
Can be mixed with liquids for easier consumption.
My notes
Sign in to keep a private note on Rutin (Quercetin-3-rutinoside).